It is essential to work closely with a healthcare provider to determine the appropriate length of treatment for your unique situation
We hope the updated GLP-1 Agonist Informed Consent Guide will be a helpful resource for patients and healthcare professionals navigating the evolving landscape of research surrounding these medications
On October 7, compounding pharmacy advocacy groups, including the Outsourcing Facilities Association, sued the FDA, arguing that the agency did not follow the appropriate procedure and that its determination was based on flawed metrics that give an incomplete picture of demand for tirzepatide
doi:10.1186/1477-5751-7-4
None produce the continuous, pharmaceutical-level GLP-1 receptor activation that drives dramatic weight loss with medications like semaglutide
Qazi NG, Khan A-u, Abbasi SW, Shah FA, Rasheed F, Ali F, et al